Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Adial Pharmaceuticals Inc
ADIL | US
2.36
USD-0.09
-3.67%
ADIL | US
About Adial Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
2.36
Open
2.46
High
2.46
Low
2.35
Adial Pharmaceuticals Inc. a clinical-stage biopharmaceutical company focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04 a serotonin-3 antagonist which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals Inc. was founded in 2010 and is based in Charlottesville Virginia.
View LessADIL | US
Risk
140.0
Sharpe
-0.66
Luna's Score
40/100
Recommendation
Sell
Luna says (ADIL | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
172.7%1 month
140.0%3 months
104.6%6 months
92.8%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.45
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-0.49
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-7.27M
MarketCap
15.12M
MarketCap(USD)
15.12M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-320.96
Short ratio
0.72
Short perc.
1.24
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.92
Range1M
1.25
Range3M
1.25
Volumes: Market Activity
Rel. volume
0.11
Price X volume
51.68K
